Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Crofelemer

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,624Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Health Reports Positive Phase 3 Results For Crofelemer
    Jaguar Health Reports Positive Phase 3 Results For Crofelemer

    01 Oct 2024

    // ACCESSWIRE

    https://www.accesswire.com/925756/jaguar-health-reports-statistically-significant-improvement-in-breast-cancer-patients-in-its-phase-3-ontarget-trial-for-its-cancer-supportive-care-drug-crofelemer

    ACCESSWIRE
    01 Oct 2024
    Share Share
    Jaguar Health To Explore Crofelemer For Breast And Lung Cancer
    Jaguar Health To Explore Crofelemer For Breast And Lung Cancer

    05 Aug 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=896292&lang=en

    ACCESSWIRE
    05 Aug 2024
    Share Share
    Jaguar Health To Report Phase 3 Crofelemer Results On July 23
    Jaguar Health To Report Phase 3 Crofelemer Results On July 23

    18 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=889979&lang=en

    ACCESSWIRE
    18 Jul 2024
    Share Share
    Jaguar Health To Report Phase 3 OnTarget Trial Results By July 23
    Jaguar Health To Report Phase 3 OnTarget Trial Results By July 23

    12 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=876430&lang=en

    ACCESSWIRE
    12 Jun 2024
    Share Share
    Jaguar Health: Positive Crofelemer Trial Results For Functional Diarrhea
    Jaguar Health: Positive Crofelemer Trial Results For Functional Diarrhea

    28 May 2024

    // ACCESSWIRE

    https://www.accesswire.com/867976/investigator-initiated-trial-of-jaguar-healths-crofelemer-yields-positive-results-for-functional-diarrhea

    ACCESSWIRE
    28 May 2024
    Share Share
    Jaguar MVID, SBS Trial Applications In Europe
    Jaguar MVID, SBS Trial Applications In Europe

    09 May 2024

    // ACCESSWIRE

    https://www.accesswire.com/861398/jaguar-health-announces-submission-of-clinical-trial-applications-for-crofelemer-for-the-rare-disease-indications-microvillus-inclusion-disease-mvid-and-short-bowel-syndrome-sbs-in-europe

    ACCESSWIRE
    09 May 2024
    Share Share